Nirmidas Biotech

Nirmidas Biotech provides innovative solutions to life science and healthcare problems and aims to improve the quality of human life. Nirmidas develops and manufactures breakthrough technologies in biological testing, assays, and imaging, based on a novel red to near-infrared fluorescence enhancing detection platform. We aim to develop personal and portable diagnostic systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening applications. Our products lie at the intersection of life science research, in vitro diagnosis, and digital healthcare.
Company Growth (employees)
Type
Private
HQ
Palo Alto, US
Founded
2013
Size (employees)
11 (est)
Nirmidas Biotech was founded in 2013 and is headquartered in Palo Alto, US

Key People/Management at Nirmidas Biotech

Meijie Tang

Meijie Tang

CEO

Nirmidas Biotech Office Locations

Nirmidas Biotech has an office in Palo Alto
Palo Alto, US (HQ)
2627 Hanover St

Nirmidas Biotech Financials and Metrics

Summary Metrics

Founding Date

2013

Total Funding

$2 m

Latest funding size

$2 m

Time since last funding

over 3 years

Investors

Nirmidas Biotech's latest funding round in August 2014 was reported to be $2 m. In total, Nirmidas Biotech has raised $2 m

Nirmidas Biotech's Web-traffic and Trends

Nirmidas Biotech Online and Social Media Presence

Nirmidas Biotech Company Life and Culture

You may also be interested in